Trajectory patterns and cumulative burden of CEA during follow-up with non-small cell lung cancer outcomes: A retrospective longitudinal cohort study

被引:2
|
作者
Li, Chunxia [1 ]
Liu, Lizhu [2 ]
You, Ruimin [2 ]
Li, Yanli [2 ]
Pu, Hongjiang [3 ]
Lei, Ming [4 ]
Fan, Bingbing [1 ]
Lv, Jiali [1 ]
Liu, Mengmei [5 ]
Yan, Guanghong [5 ]
Li, Zhenhui [2 ]
You, Dingyun [5 ,6 ]
Zhang, Tao [1 ]
机构
[1] Shandong Univ, Cheeloo Coll Med, Sch Publ Hlth, Dept Biostat, Jinan 250012, Shandong, Peoples R China
[2] Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Dept Radiol,Yunnan Canc Ctr, Kunming 650118, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Dept Colorectal Surg,Yunnan Canc Ctr, Kunming 650118, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Dept Clin Lab Med,Yunnan Canc Ctr, Kunming 650118, Peoples R China
[5] Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Yunnan, Peoples R China
[6] Kunming Med Univ, Yunnan Prov Key Lab Publ Hlth & Biosafety, Kunming 650500, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
SERUM CARCINOEMBRYONIC ANTIGEN; PROGNOSTIC-SIGNIFICANCE; SURGERY; LEVEL;
D O I
10.1038/s41416-024-02678-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPrevious studies of non-small cell lung cancer (NSCLC) focused on CEA measured at a single time point, ignoring serial CEA measurements.MethodsThis retrospective cohort included 2959 patients underwent surgery for stage I-III NSCLC. CEA trajectory patterns and long-term cumulative CEA burden were evaluated using the latent class growth mixture model.ResultsFour CEA trajectory groups were identified, named as low-stable, decreasing, early-rising and later-rising. Compared with the low-stable group, the adjusted hazard ratios associated with death were 1.27, 4.50, and 3.68 for the other groups. Cumulative CEA burden were positively associated with the risk of death in patients not belonging to the low-stable group. The 5-year overall survival (OS) rates decreased from 62.3% to 33.0% for the first and fourth quantile groups of cumulative CEA burden. Jointly, patients with decreasing CEA trajectory could be further divided into the decreasing & low and decreasing & high group, with 5-year OS rates to be 77.9% and 47.1%. Patients with rising CEA trajectory and high cumulative CEA were found to be more likely to develop bone metastasis.ConclusionsLongitudinal trajectory patterns and long-term cumulative burden of CEA were independent prognostic factors of NSCLC. We recommend CEA in postoperative surveillance of NSCLC.
引用
收藏
页码:1803 / 1808
页数:6
相关论文
共 50 条
  • [1] Postoperative follow-up in non-small cell lung cancer
    Westeel, V
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S90 - S93
  • [2] Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer
    Nakamura, Ryota
    Kurishima, Koichi
    Kobayashi, Naohiro
    Ishikawa, Shigemi
    Goto, Yukinobu
    Sakai, Mitsuaki
    Onizuka, Masataka
    Ishikawa, Hiroichi
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    Sato, Yukio
    ONKOLOGIE, 2010, 33 (1-2): : 14 - 18
  • [3] Evidence-based follow-up in non-small cell lung cancer
    Watzka, Stefan B.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 69 - 72
  • [4] Evidence-based follow-up in non-small cell lung cancer
    Stefan B. Watzka
    memo - Magazine of European Medical Oncology, 2020, 13 : 69 - 72
  • [5] Follow-up in non-small-cell lung cancer
    Rothschild S.I.
    Lardinois D.
    Bremerich J.
    Tamm M.
    Bubendorf L.
    Papachristofilou A.
    Stoll H.
    Zippelius A.
    memo - Magazine of European Medical Oncology, 2014, 7 (2) : 97 - 101
  • [6] Recurrence Dynamic of Completely Resected Non-Small Cell Lung Cancer in Perspective of Follow-Up Surveillance
    Kim, Eung Rae
    Park, In Kyu
    Hyun, Kwanyong
    Park, Samina
    Hwang, Yoohwa
    Kang, Chang Hyun
    Kim, Young Tae
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1395 - S1395
  • [7] Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
    Barak, Vivian
    Holdenrieder, Stefan
    Nisman, Benjamin
    Stieber, Petra
    CANCER BIOMARKERS, 2010, 6 (3-4) : 191 - 196
  • [8] Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study
    Ilonen, Ilkka K.
    Rasanen, Jari V.
    Knuuttila, Aija
    Sihvo, Eero I.
    Sintonen, Harri
    Sovijarvi, Anssi R. A.
    Salo, Jarmo A.
    LUNG CANCER, 2010, 70 (03) : 347 - 351
  • [9] Treatment patterns and long-term survival outcomes for patients with stage III non-small cell lung cancer: A retrospective study
    Kumari, Seema
    Karikios, Deme
    Yeghiaian-Alvandi, Roland
    Flynn, Peter
    Morgan, Lucy
    Kay, Lisa
    Ding, Pei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (01) : 25 - 31
  • [10] IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer
    Westeel, V.
    Lebitasy, M. P.
    Mercier, M.
    Girard, P.
    Barlesi, F.
    Blanchon, F.
    Tredaniel, J.
    Bonnette, P.
    Woronoff-Lemsi, M. C.
    Breton, J. L.
    Azarian, R.
    Falcoz, P. E.
    Friard, S.
    Geriniere, L.
    Laporte, S.
    Lemarie, E.
    Quoix, E.
    Zalcman, G.
    Guigay, J.
    Morin, F.
    Milleron, B.
    Depierre, A.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (05) : 645 - 652